AbbVie Total Current Liabilities 2010-2024 | ABBV

AbbVie total current liabilities for the quarter ending September 30, 2024 were $43.062B, a 23.84% increase year-over-year.

  • AbbVie total current liabilities for 2023 were $37.841B, a 28.11% increase from 2022.
  • AbbVie total current liabilities for 2022 were $29.538B, a 16.07% decline from 2021.
  • AbbVie total current liabilities for 2021 were $35.194B, a 22.79% increase from 2020.

AbbVie Total Current Liabilities 2010-2024 | ABBV

  • AbbVie total current liabilities for 2023 were $37.841B, a 28.11% increase from 2022.
  • AbbVie total current liabilities for 2022 were $29.538B, a 16.07% decline from 2021.
  • AbbVie total current liabilities for 2021 were $35.194B, a 22.79% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$710.1B
Novo Nordisk (NVO)$471.5B
Johnson & Johnson (JNJ)$373.6B
Merck (MRK)$250.9B
Novartis AG (NVS)$213.1B
AstraZeneca (AZN)$203.5B
Pfizer (PFE)$145.4B
Sanofi (SNY)$122.5B
Innoviva (INVA)$1.2B